Crispr Therapeutics shares owned by Westside Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Westside Investment Management
from 13F filings
Historical chart of Westside Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Westside Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Crispr Therapeutics by Westside Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $392k | 6.0k | 64.81 |
| 2025-06-30 | $340k | 7.0k | 48.64 |
| 2025-03-31 | $270k | 7.9k | 34.03 |
| 2024-12-31 | $242k | 6.2k | 39.36 |
| 2024-09-30 | $303k | 6.4k | 46.98 |
| 2024-06-30 | $403k | 7.5k | 54.01 |
| 2024-03-31 | $504k | 7.4k | 68.16 |
| 2023-12-31 | $442k | 7.1k | 62.60 |
| 2023-09-30 | $318k | 7.0k | 45.39 |
| 2023-06-30 | $394k | 7.0k | 56.14 |
| 2023-03-31 | $323k | 7.1k | 45.23 |
| 2022-12-31 | $314k | 7.7k | 40.59 |
| 2022-09-30 | $505k | 7.7k | 65.35 |
| 2022-06-30 | $469k | 7.7k | 60.68 |
| 2022-03-31 | $497k | 7.9k | 62.72 |
| 2021-12-31 | $580k | 7.7k | 75.65 |
| 2021-09-30 | $420k | 3.8k | 111.90 |
| 2021-06-30 | $471k | 2.9k | 161.80 |
| 2021-03-31 | $342k | 2.8k | 121.79 |
| 2020-12-31 | $45k | 300 | 150.00 |
| 2020-09-30 | $32k | 400 | 80.00 |
| 2020-06-30 | $43k | 612 | 70.51 |
| 2020-03-31 | $36k | 862 | 41.98 |
| 2019-06-30 | $4.0k | 100 | 40.00 |
| 2018-12-31 | $2.9k | 100 | 28.57 |
| 2018-09-30 | $4.2k | 100 | 42.34 |
| 2018-06-30 | $6.0k | 100 | 60.05 |
| 2017-12-31 | $2.6k | 100 | 26.07 |
| 2017-09-30 | $2.0k | 100 | 19.70 |
| 2017-06-30 | $1.6k | 100 | 16.03 |
| 2017-03-31 | $2.0k | 100 | 19.85 |
More positions owned by Westside Investment Management
View all positions for Westside Investment Management